Regulators must move quickly on CBD regulation

7 June 2019 - Deborah Wilkes

The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is like the "wild west".